Summary:
This is a blinded and placebo-controleed study of topical testosterone replacement therpay (TRT) in symptomatic hypogonaldal men with increased risk for cardiovascular (CV) disease.
Qualified Participants Must:
• Men between 45 and 80 years age
• Participants with low serum testosterone concentrations less than 300ng/dL who exhibit at least one sign or symptom of hypogonadism and have evidence of cardiovascular (CV) disease or are at an increased risk for CV disease
Qualified Participants May Receive:
Compensation for time and travel